![Ravi Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ravi Rao
Directeur/Membre du Conseil chez
DBV TECHNOLOGIES
Fortune : - $ au 31/08/2026
Profil
Le Dr Ravi M. Rao est médecin en chef chez Swedish Orphan Biovitrum AB et membre du Royal College of Physicians. Il est membre du conseil d'administration de DBV Technologies SA. Auparavant, le Dr Rao a été employé comme directeur médical chez Aeglea Biotherapeutics, Inc. et comme responsable des affaires médicales mondiales chez GlaxoSmithKline Plc. Il a obtenu son diplôme de premier cycle à l'université de Cambridge et un doctorat à l'Imperial College de Londres.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Ravi Rao
| Sociétés | Poste | Début |
|---|---|---|
| DBV TECHNOLOGIES | Directeur/Membre du Conseil | 19/05/2021 |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/04/2024 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Directeur Technique/Scientifique/R&D | 01/04/2022 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 01/03/2022 |
Anciens postes connus de Ravi Rao
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/11/2023 |
| SWEDISH ORPHAN BIOVITRUM AB | Directeur Technique/Scientifique/R&D | 01/01/2022 |
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 10/08/2020 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Formation de Ravi Rao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
